Optinose Inc Share Price

NASDAQ: OPTN

$9.62

-0.09

(-0.93%)

as on May 21, 2025 at 1:29 am IST

$₹

The stock has been delisted from the stock exchange on 20 May 2025

Optinose Inc Stock Performance

as on May 21, 2025 at 1:29 am IST

$9.62
Day's Price Range
$9.62
$9.62
52 Week's Low
52 Week's High
$4.82
52-Week Price Range
$14.25
$9.62
49.95%
Downside
48.13%
Upside

Optinose Inc share price movements today

Previous Close: $9.71
Open: $9.62
Volume: 6.2K
Day's Low - High: $9.62 - $9.62
52 Week Low - High: $4.82 - $14.25

Optinose Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Optinose Inc Stock Fundamentals & Key Indicators

Check Optinose Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

0.00%

Optinose Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Optinose Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Optinose Inc	BUY	$-	NA	NA	0.00%

Analyst Recommendation on Optinose Inc Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Optinose Inc. Average target price of $18

Optinose Inc Share Price Target

Get share price movements and forecasts by analysts on Optinose Inc.

What analysts predicted

46.56%UPSIDE

Target Price

$18

Current Price

$9.62

Analyzed by

10 Analysts

Target

$18.00

Optinose Inc target price $18, a slight upside of 46.56% compared to current price of $9.62. According to 10 analysts rating.

Optinose Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	20	11	19	19	19	14	20	20	22	18
Gross Profit	17	10	16	17	17	13	18	18	20	16
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-17	-18	2	-9	-9	-14	-7	0	0	-22
Net Profit Margin	-83.10%	-157.47%	13.50%	-46.88%	-50.17%	-94.54%	-37.00%	2.29%	-1.61%	-121.10%

Optinose Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	47	0	7	34	49	74	76	70	78
Gross Profit	0	47	0	5	29	41	65	67	62	70
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-28	22	-48	-106	-108	-98	-81	-76	-35	-21
Net Profit Margin	-33310.59%	47.61%	-30186.42%	-1509.67%	-314.59%	-200.20%	-109.37%	-100.16%	-49.99%	-27.54%

Global Institutional Holdings in Optinose Inc

Funds	Holdings
FMR Inc	10.63%
Nantahala Capital Management, LLC	9.73%
Vanguard Group Inc	2.9%
Bleichroeder LP	2.66%
Opaleye Management Inc	1.91%

See all

About Optinose Inc

OptiNose, Inc. is a specialty pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing its Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE combines the EDS with a liquid formulation of fluticasone propionate, a well-characterized, second-generation corticosteroid. XHANCE is designed to deliver medication into the high and deep regions of the nasal passages where both nasal polyps and inflamed and swollen membranes can obstruct normal sinus ventilation and drainage. It has developed both a liquid delivery EDS and a powder delivery EDS utilizing natural functional behaviors of the upper nasal airways intended to offer better drug deposition.

Organisation	Optinose Inc
E-voting on shares	Click here to vote

FAQs

What is Optinose Inc share price today?

Optinose Inc share price today is $9.62 as on May 21, 2025 at 1:29 am IST at the close of the market. Optinose Inc share today touched a day high of $9.62 and a low of $9.62.

What is the 52 week high and 52 week low for Optinose Inc share?

Optinose Inc share touched a 52 week high of $14.25 on September 16, 2024 and a 52 week low of $4.82 on November 20, 2024. Optinose Inc stock price today i.e. May 21, 2025 at 1:29 am IST is closed at $9.62,which is 32.49% down from its 52 week high and 99.79% up from its 52 week low.

How to invest in Optinose Inc Stock (OPTN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Optinose Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Optinose Inc Shares that will get you 0.1559 shares as per Optinose Inc share price of $9.62 per share as on May 21, 2025 at 1:29 am IST.

What is the minimum amount required to buy Optinose Inc Stock (OPTN) from India?

Indian investors can start investing in Optinose Inc (OPTN) shares with as little as ₹88.27 or $1 (as of September 14, 2025 at 5:33 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Optinose Inc stock (as per the Rupee-Dollar exchange rate as on September 14, 2025 at 5:33 pm IST). Based on Optinose Inc share’s latest price of $9.62 as on May 21, 2025 at 1:29 am IST, you will get 1.0395 shares of Optinose Inc. Learn more about fractional shares .